COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Quantifying Drug Adherence and Drug Exposure to Antiretroviral Therapy

Completed

Conditions: HIV/AIDS

First Posted Date: 2013-12-16

Last Posted Date: 2019-11-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 807

Registration Number: NCT02012621

Locations: 🇺🇸
University of Colorado-Anschutz Medical Campus, Aurora, Colorado, United States

Esophageal String Test in Eosinophilic Esophagitis

Active, not recruiting

Conditions: Eosinophilic Esophagitis

First Posted Date: 2013-12-11

Last Posted Date: 2024-03-29

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 440

Registration Number: NCT02008903

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
OSF St Francis Medical Center, Peoria, Illinois, United States
🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

and more 3 locations

Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults

Not Applicable

Completed

Conditions: Metabolic Syndrome
Diabetes
Aging

Interventions: Other: US
Other: IW
Other: CW

First Posted Date: 2013-11-27

Last Posted Date: 2021-08-24

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 25

Registration Number: NCT01997021

Locations: 🇺🇸
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States

A Pilot Study to Enhance F18 FDG-PET Imaging of Prostate Cancers With the Metabolic Inhibitor Ranolazine

Not Applicable

Completed

Conditions: Soft Tissue Metastases
Stage IV Prostate Cancer
Stage IIA Prostate Cancer
Stage III Prostate Cancer
Adenocarcinoma of the Prostate
Stage IIB Prostate Cancer
Bone Metastases

Interventions: Drug: Ranolazine

First Posted Date: 2013-11-25

Last Posted Date: 2018-12-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 11

Registration Number: NCT01992016

Locations: 🇺🇸
University of Colorado Cancer Center, Aurora, Colorado, United States

Exercise and Type 2 Diabetes: Gender and Endothelial Function

Not Applicable

Completed

Conditions: Type 2 Diabetes

Interventions: Other: Supervised Exercise Training

First Posted Date: 2013-11-25

Last Posted Date: 2013-11-25

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 40

Registration Number: NCT01993121

Locations: 🇺🇸
University of Colorado, Anschutz Medical Campus, Aurora, Colorado, United States

Optimal Timing of Exercise Initiation Within a Lifestyle Weight Loss Program

Not Applicable

Completed

Conditions: Obesity

Interventions: Behavioral: Standard BT
Behavioral: Sequential BT

First Posted Date: 2013-11-15

Last Posted Date: 2023-09-28

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 170

Registration Number: NCT01985568

Locations: 🇺🇸
University of Colorado, Anschutz Health and Wellness Center, Aurora, Colorado, United States

Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry

Not Applicable

Terminated

Conditions: Pain

Interventions: Drug: oral placebo
Drug: Oral Analgesics

First Posted Date: 2013-10-29

Last Posted Date: 2021-01-22

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 88

Registration Number: NCT01971853

Locations: 🇺🇸
Children's Hospital Colorado, Aurora, Colorado, United States

Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study

Phase 2

Completed

Conditions: Uterine Hemorrhage
Contraception

Interventions: Drug: Placebo Sugar Pill
Drug: Combined Oral Contraceptive Pill

First Posted Date: 2013-10-23

Last Posted Date: 2016-05-05

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 32

Registration Number: NCT01968135

Locations: 🇺🇸
University of Colorado, Aurora, Colorado, United States

Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes

Not Applicable

Completed

Conditions: Type 2 Diabetes
Cardiovascular Disease

Interventions: Drug: Sitagliptin
Drug: Glimepiride
Drug: Placebo

First Posted Date: 2013-09-26

Last Posted Date: 2023-07-12

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 36

Registration Number: NCT01951339

Locations: 🇺🇸
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States

DS-Connect®: The Down Syndrome Registry

Recruiting

Conditions: Down Syndrome

First Posted Date: 2013-09-25

Last Posted Date: 2025-01-31

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 100000

Registration Number: NCT01950624

Locations: 🇺🇸
Linda Crnic Institute for Down Syndrome, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy